As part of new agreements announced at the 7th edition of the Global Health Forum, Saudi Arabia signed deals to localize the ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

Diabetes is a global health concern, making it essential to ensure a continuous and reliable supply of high-quality insulin ...

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and health care company, has ...

The settlement announced by Attorney General Bridget Hill on Friday morning with Sanofi-Aventis U.S. will be put into effect within 90 days of Sept. 27. The cost of insulin has soared over the ...

The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin. Texas alleged drug manufacturers Eli Lilly, Novo Nordisk and Sanofi ...

France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...

NUPCO signs over 15 new MoUs at the Global Health Exhibition 2024, deepening its ties with the private sector and advancing ...

The Global Health Exhibition 2024 witnessed today, Oct. 22, the signing of a final agreement to localize the production of ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and healthcare company, has ...